FINESSE: Fremanezumab for Preventive Treatment in Migraine

被引：0
|
作者：
Straube, A. [1 ]
Broessner, G. [2 ]
Gaul, C. [3 ]
Hamann, X. [4 ]
Kraya, T. [5 ]
Schauerte, I. [6 ]
Neeb, L. [7 ]
机构：
[1] Ludwig Maximilians Univ Munchen, Neurol, Munich, Germany
[2] Med Univ Innsbruck, Neurol, Innsbruck, Austria
[3] Migrane & Kopfschmerz Klin Konigstein, Koenigstein, Germany
[4] Teva GmbH, Ulm, Germany
[5] Klinikum St Georg, Klin & Poliklin Neurol, Leipzig, Germany
[6] Inst Dr Schauerte, Munich, Germany
[7] Charite, Neurol, Berlin, Germany
来源：
CEPHALALGIA | 2021年 / 41卷 / 1_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P0325
引用
收藏
页码：174 / 175
页数：2
相关论文
共 50 条
  • [1] FINESSE: Fremanezumab for Preventive Treatment in Migraine
    Straube, A.
    Broessner, G.
    Gaul, C.
    Hamann, X.
    Kraya, T.
    Schauerte, I.
    Neeb, L.
    [J]. JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 117 - 117
  • [2] Fremanezumab for Preventive Treatment in Migraine: The FINESSE Study
    Straube, Andreas
    Broessner, Gregor
    Gaul, Charly
    Hamann, Xenia
    Kraya, Torsten
    Schauerte, Isabel
    Neeb, Lars
    [J]. NEUROLOGY, 2022, 98 (18)
  • [3] Fremanezumab for the preventive treatment of migraine
    Silberstein, Stephen D.
    Cohen, Joshua M.
    Yeung, Paul P.
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2019, 19 (08) : 763 - 771
  • [4] Fremanezumab for the preventive treatment of migraine in adults
    Lionetto, Luana
    Curto, Martina
    Cisale, Giusy Ylenia
    Capi, Matilde
    Cipolla, Fabiola
    Guglielmetti, Martina
    Martelletti, Paolo
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2019, 12 (08) : 741 - 748
  • [5] Fremanezumab for the Preventive Treatment of Chronic Migraine
    Silberstein, Stephen D.
    Dodick, David W.
    Bigal, Marcelo E.
    Yeung, Paul P.
    Goadsby, Peter J.
    Blankenbiller, Tricia
    Grozinski-Wolff, Melissa
    Yang, Ronghua
    Ma, Yuju
    Aycardi, Ernesto
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (22): : 2113 - 2122
  • [6] Response to fremanezumab for preventive treatment in migraine in routine clinical practice: First data from the FINESSE study
    Straube, A.
    Broessner, G.
    Gaul, C.
    Hamann, X.
    Kraya, T.
    Schaurete, I
    Carr, K.
    Neeb, L.
    [J]. HEADACHE, 2022, 62 : 160 - 161
  • [7] Fremanezumab as a preventive treatment for episodic and chronic migraine
    Bigal, Marcelo E.
    Walter, Sarah
    Rapoport, Alan M.
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2019, 19 (08) : 719 - 728
  • [8] Early Onset of Efficacy With Fremanezumab for the Preventive Treatment of Chronic Migraine
    Winner, Paul K.
    Spierings, Egilius L. H.
    Yeung, Paul P.
    Aycardi, Ernesto
    Blankenbiller, Tricia
    Grozinski-Wolff, Melissa
    Yang, Ronghua
    Ma, Yuju
    [J]. HEADACHE, 2019, 59 (10): : 1743 - 1752
  • [9] Effectiveness of fremanezumab for preventive treatment of migraine: the observational PEARL study
    Ashina, M.
    Mitsikostas, D.
    Amin, F.
    Kokturk, P.
    Poole, A.
    Sahin, G.
    Schankin, C.
    Nezadal, T.
    Lyras, L.
    Ning, X.
    Krasenbaum, L.
    Tassorelli, C.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 192 - 193
  • [10] Efficacy and tolerability of fremanezumab for migraine preventive treatment in Korean patients with chronic or episodic migraine
    Kim, Byung-Kun
    Cohen, Joshua
    Kim, Sukyung
    Chang, Daeho
    Ning, Xiaoping
    Lengil, Tamar
    Janka, Lindsay
    Barash, Steve
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 214 - 214
12345